| BALCX | FKIQX | BALCX / FKIQX | |
| Total Expense Ratio | 1.30 | 0.71 | 183% |
| Annual Report Gross Expense Ratio | 1.30 | 0.71 | 183% |
| Fund Existence | 25 years | 8 years | - |
| Gain YTD | 8.876 | 5.589 | 159% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 288B | 79.7B | 361% |
| Annual Yield % from dividends | 1.14 | 5.16 | 22% |
| Returns for 1 year | 12.30 | 11.06 | 111% |
| Returns for 3 years | 39.03 | 32.25 | 121% |
| Returns for 5 years | 29.99 | 30.84 | 97% |
| Returns for 10 years | 76.31 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RAGHX | 29.89 | 0.83 | +2.86% |
| Virtus KAR Health Sciences A | |||
| CCCNX | 7.80 | 0.06 | +0.78% |
| Center Coast Brookfield Midstream Foc I | |||
| MCIMX | 27.00 | 0.13 | +0.48% |
| Victory Integrity Mid-Cap Value C | |||
| CVERX | 18.66 | 0.01 | +0.05% |
| Columbia Select Mid Cap Value Instl 2 | |||
| FCGSX | 33.00 | -0.39 | -1.17% |
| Fidelity Series Growth Company | |||